This result concurs with a colon cancer study in which a COX-2-degrading enzyme was upregulated by TGFβ1 (35), suggesting that the long-term exposure of PCa cells to TGFβ1 may have a similar COX-2 suppression mechanism. The gene discussed is TGFB1; the disease is colonic neoplasm.